A phase 1 study of belinostat (PXD101) in combination with bortezomib in patients with advanced solid tumors and lymphoma

被引：0
|
作者：
O'Bryant, Cindy L. [1 ]
Leong, Stephen [1 ]
Camidge, D. Ross [1 ]
Gore, Lia [1 ]
Diab, Sami [1 ]
Gustafson, Dan L. [2 ]
Call, Justin [1 ]
Spratlin, Jennifer [1 ]
Zwiebel, James A. [3 ]
Eckhardt, S. Gail [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
[2] Colorado State Univ, Ft Collins, CO USA
[3] NCI Canc Therapy Evaluat Program, Bethesda, MD USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3384S / 3384S
页数：1
相关论文
共 50 条
  • [1] A phase 1 study of belinostat (PXD101) in combination with bortezomib in patients with advanced solid tumors or lymphoma
    Nallapareddy, Sujatha
    Leong, Stephen
    Camidge, Ross
    Gore, Lia
    Diab, Sami
    Messersmith, Wells
    Lewis, Karl
    Weekes, Colin
    Gustafson, Daniel
    Jimeno, Antonio
    Zwiebel, James
    -Delgado, Igor Espinoza
    Eckhardt, Gail
    O'Bryant, Cindy
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [2] A phase I study of oral belinostat (PXD101) in patients with advanced solid tumors
    Kelly, W. K.
    Yap, T.
    Lee, J.
    Lassen, U.
    Crowley, E.
    Clarke, A.
    Hawthorne, T.
    Buhl-Jensen, P.
    de Bono, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] A phase I study of oral belinostat (PXD101) in patients with advanced solid tumors
    Molife, Rhoda
    Lee, James
    Petrylak, Daniel
    Blumenschein, George, Jr.
    Lassen, Ulrik
    Clark, Jayme
    Yap, Timothy
    Rowen, Elin
    Ang, Jooern
    Crowley, Elizabeth
    Clarke, Anne
    Hawthorne, Thomas
    Buhl-Jensen, Peter
    De Bono, Johann
    Kelly, Wm Kevin
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3476S - 3476S
  • [4] Final results of a phase I study of oral belinostat (PXD101) in patients with solid tumors
    Kelly, W. K.
    DeBono, J.
    Blumenschein, G.
    Lassen, U.
    Zain, J.
    O'Connor, O.
    Foss, F.
    Tjornelund, J.
    Fagerberg, J.
    Petrylak, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Final results of a phase I study of oral belinostat (PXD101) in patients with lymphoma
    Zain, J. M.
    Foss, F.
    Kelly, W. K.
    DeBono, J.
    Petrylak, D.
    Narwal, A.
    Neylon, E.
    Blumenschein, G.
    Lassen, U.
    O'Connor, O. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] A phase Ib/II study of PXD101 alone and in combination with 5-fluorouracil in patients with advanced solid tumors
    Northfelt, D. W.
    Marschke, R. F., Jr.
    Bonnem, E.
    Ooi, C. E.
    Gerwien, R.
    Hawthorne, T.
    Clarke, A.
    Buhl-Jensen, P.
    Von Hoff, D.
    Grem, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Phase I study of belinostat (PXD101) plus azacitidine (AZC) in patients with advanced myeloid neoplasms
    Odenike, O.
    Green, M.
    Larson, R. A.
    Rich, E. S.
    Ott, J.
    Ratain, M. J.
    Stock, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] A Phase Ib safety and pharmacodynamic study of PXD101 alone and in combination with 5-fluorouracil in patients with advanced solid tumors
    Northfelt, D.
    Ooi, C. E.
    Gerwien, R.
    Hawthorne, T.
    Clarke, A.
    Jones, S.
    Rodriguez, G.
    Buhl-Jensen, P.
    Von Hoff, D.
    Grem, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 57 - 57
  • [9] A phase I/II study of belinostat (PXD101) in patients with unresectable hepatocelluar carcinoma
    Yeo, W.
    Lim, R.
    Ma, B. B.
    Hui, P.
    Chan, L.
    Mo, F. K.
    Yu, S. C.
    Ho, S. S.
    Koh, J.
    Chan, A. T.
    Goh, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Belinostat (PXD101) in patients with recurrent or refractory peripheral or cutaneous T-Cell lymphoma: Results of a phase II study
    Advani, Ranjana
    Hymes, K.
    Pohlman, B.
    Jacobsen, E.
    McDonnell, J.
    Belt, R.
    Lerner, A.
    Kim, Y.
    Mundis, R.
    Mansfield, T.
    Buhl-Jensen, P.
    Ooi, C. E.
    Duvic, M.
    Foss, F.
    BLOOD, 2007, 110 (11) : 1012A - 1012A
12345